Education

  2. Home
  3. Education
Page 1 of 3
Results 1 - 75 of 157
9193-case1
Identifying the Signs and Symptoms of PPF
9165 pneumo explore
Utilizing ACIP's Updated Pneumococcal Recommendations
9166-covid
Reducing the Risk of Severe Illness for Patients With COVID-19
9157-mod2
Treating Complex Cases of NTM-LD
9157-mod1
NTM-LD Diagnosis and Management
No image set
ILD Patient Case Library: IPF, PF-ILD, SSc-ILD, and Post COVID-19
9089_nsclc_titleslide
TARGET for NSCLC: Genomic Pathways and Use of EGFR Therapies
No image set
PAH: Risk Reduction Strategies Using Single and Combination Therapies
9102-chest-slides
Slides: IPF Management and Antifibrotic Therapy
9088-covid-slides
Slides: Post COVID-19 and Patients With and Without Pre-existing ILD
9088-ipf-slides
Slides: A Collaborative Approach to IPF Management
9088-sscild-slides
Slides: Practical Solutions to SSc-ILD Treatment
No image set
Improved Patient Outcomes in PAH
9088-pfild-slides8
Slides: A New Paradigm in Treating ILD
9101-chest
IPF Management and Antifibrotic Therapy
No image set
How to Develop an Effective Risk Reduction Strategy in Pulmonary Arterial Hypertension
No image set
Pulmonary Arterial Hypertension (PAH) - Therapy Options Explained
No image set
EXPLORE Learning Experience: COVID-19 and Monoclonal Antibodies
No image set
EXPLORE Learning Experience: Understanding and Managing NTM-Lung Disease
No image set
A New Paradigm in Treating ILD
No image set
A Collaborative Approach to IPF Management
No image set
Practical Solutions to SSc-ILD Treatment
No image set
Post COVID-19 and Patients With and Without Pre-existing ILD
No image set
How to Choose the Right Therapy for Your Patients with IPF
No image set
PAH: Aligning Treatment Strategy to Risk Level
No image set
PAH: Identifying Side Effects and Optimizing Therapy to Improve Patient Outcomes
No image set
Patient Develops de novo Features of ILD After a COVID Infection
No image set
SSc-ILD Individualized Treatment
No image set
Overlapping Symptoms and Risk Factors for COVID and IPF
No image set
Multidisciplinary Management of IPF
No image set
Fundamentals of Diagnosis: SSc-ILD
No image set
Fundamentals of Diagnosis: PF-ILD
No image set
Beyond The Basics Of PAH
No image set
IPF Management in Practice: A Truly Interactive Experience
No image set
COVID-19 Associated ARDS
No image set
COVID-19 and Comorbid ILD
No image set
Three Cases of Lung Fibrosis in Patients With COVID-19
No image set
Assessing a Patient With Long COVID-19
No image set
COVID-19 Acute and Long-term Lung Injury
No image set
COVID-19: An Animated Video Series
No image set
COVID-19 and ARDS: East Coast Experiences
No image set
IPF Animated Video Series: Micro-learning focusing on the soft skills
No image set
Practical Applications From What We Heard at Virtual ACR
No image set
Learning From SARS and MERS: What Should We Expect for COVID-19 Patients
No image set
COVID-19 and Lung Injury/Fibrosis
No image set
End of Life in IPF
No image set
Comprehensive Care of the ILD Patient–Focus on Symptoms
No image set
Developing an Action Plan
No image set
Diagnosis of Interstitial Lung Disease
No image set
Allergic Asthma: Virtual Conference Coverage
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
New Directions in the Diagnosis of RA ILD
No image set
Therapies on the Horizon for RA ILD
No image set
New Treatment Options for SSc ILD
No image set
Updates on Current Treatment Options for RA ILD
No image set
Learnings From the Virtual ERS International Congress
No image set
Practical Questions in the Diagnosis and Management of Patients With MAC
No image set
EULAR 2020 Conference Coverage
No image set
COVID-19 and ARDS: West Coast Experiences
No image set
Biochemical Profiles of Radiographic Patterns in SSc-ILD
No image set
Factors Associated with Disease Progression in the SENSCIS Trial
No image set
Machine Learning Assisted Prediction of Progression in SSc-ILD
No image set
What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD
No image set
Efficacy of MMF in African Americans vs Non-African Americans with SSc-ILD
No image set
Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis
No image set
Updates on Current Treatment Options for RA-ILD
cc4
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
PILOTforPulmonary 2019: Data, Insights & Practice
No image set
Managing the Whole Patient with COPD: An Animated Video Series
No image set
My COPD Action Plan
No image set
Expert Recommendations for COPD
9913-nacfc3
How Can Targeting the Endocannabinoid System Help to Resolve CF Inflammation
9913-nacfc2
Previous Approaches that Tried to Target Inflammation in Cystic Fibrosis
9913-nacfc1
Inflammation in Cystic Fibrosis
Page 1 of 3

Search